Athersys, Inc. (Nasdaq: ATHX) entered into an agreement with Pfizer Inc. (NYSE: PFE) to develop and commercialize MultiStem for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE